| 000 | 01168 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517012222.0 | ||
| 264 | 0 | _c20151008 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1873-2933 | ||
| 024 | 7 |
_a10.1016/j.clinbiochem.2015.01.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGronowski, Ann M | |
| 245 | 0 | 0 |
_aAssessing the risk of false negative point-of-care urinary human chorionic gonadotropin device results due to beta core fragment. _h[electronic resource] |
| 260 |
_bClinical biochemistry _cFeb 2015 |
||
| 300 |
_a97-8 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aChorionic Gonadotropin, beta Subunit, Human _xanalysis |
| 650 | 0 | 4 | _aFalse Negative Reactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOvulation |
| 650 | 0 | 4 |
_aPeptide Fragments _xanalysis |
| 650 | 0 | 4 | _aPoint-of-Care Systems |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aReagent Kits, Diagnostic |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aNerenz, Robert D | |
| 773 | 0 |
_tClinical biochemistry _gvol. 48 _gno. 3 _gp. 97-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinbiochem.2015.01.001 _zAvailable from publisher's website |
| 999 |
_c24524747 _d24524747 |
||